Krsnaa Diagnostics signed two agreements with the Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS) and the Medical Superintendent of Sadar Hospital, Ranchi. Shares of Krsnaa Diagnostics Ltd ended at ₹859.65, up by ₹16.45, or 1.95%, on the BSE.
